Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro-Reference-Cited by-同舟云学术

Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro

Published:2023-05 Issue: Volume:307 Page:116198
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Qian Xiang,Bi Qian-Yu,Wang Zeng-Na,Han Fang,Liu Lu-Ming,Song Li-Bin,Li Chang-Yu,Zhang Ai-Qin,Ji Xu-Ming^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference55 articles.

1. Quercetin impact in pancreatic cancer: an overview on its therapeutic effects;Asgharian;Oxid. Med. Cell. Longev.,2021

2. Chaihu Guizhi Ganjiang decoction ameliorates pancreatic fibrosis via JNK/mTOR signaling pathway;Cui;Front. Pharmacol.,2021

3. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals;Chen;Biosci. Rep.,2019

4. Cell death in pancreatic cancer: from pathogenesis to therapy;Chen;Nat. Rev. Gastroenterol. Hepatol.,2021

5. Proteome analysis of Camellia nitidissima Chi revealed its role in colon cancer through the apoptosis and ferroptosis pathway;Chen;Front. Oncol.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of omics technologies in studies on antitumor effects of Traditional Chinese Medicine;Chinese Medicine;2024-09-09

2. Unraveling the Mechanisms of S100A8/A9 in Myocardial Injury and Dysfunction;Current Issues in Molecular Biology;2024-09-02

3. Qingfei mixture modulates the immune responses in lung cancer through modulating mTOR signaling and gut microbiota-derived short-chain fatty acids;Heliyon;2024-04

4. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches;Cancer Letters;2024-04

5. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis;Pathology - Research and Practice;2023-11